Thrombospondin-1, Vascular Endothelial Growth Factor Expression and Microvessel Density in Renal Cell Carcinoma and Their Relationship with Multifocality
Authors:
- Çağatay GöğüşÇGÇağatay Göğüş
- 1 July 2003
- journal article
- research article
- Published by Elsevier in European Urology
- Vol. 44 (1) , 76-81
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Thrombospondin‐1, vascular endothelial growth factor expression and their relationship with p53 status in prostate cancer and benign prostatic hyperplasiaBJU International, 2002
- Clinical significance of urinary vascular endothelial growth factor and microvessel density in patients with renal cell carcinomaUrology, 2001
- INFLUENCE OF TUMOR STAGE, SIZE, GRADE, VASCULAR INVOLVEMENT, HISTOLOGICAL CELL TYPE AND HISTOLOGICAL PATTERN ON MULTIFOCALITY OF RENAL CELL CARCINOMAJournal of Urology, 2000
- LONG-TERM RESULTS OF NEPHRON SPARING SURGERY FOR LOCALIZED RENAL CELL CARCINOMA: 10-YEAR FOLLOWUPJournal of Urology, 2000
- Increased Serum Levels of Vascular Endothelial Growth Factor in Patients with Renal Cell CarcinomaJapanese Journal of Cancer Research, 1999
- A human fibrosarcoma inhibits systemic angiogenesis and the growth of experimental metastases via thrombospondin-1Proceedings of the National Academy of Sciences, 1998
- Vascular Endothelial Growth Factor Expression is Increased in Renal Cell CarcinomaJournal of Urology, 1997
- Thrombospondin-1 Expression in Bladder Cancer: Association With p53 Alterations, Tumor Angiogenesis, and Tumor ProgressionJNCI: Journal of the National Cancer Institute, 1997
- Intrarenal satellites of renal cell carcinoma: Histopathologic manifestation and clinical implicationUrology, 1995
- Clinical Comparison Between Vascular and Avascular Renal Cell CarcinomaJournal of Urology, 1976